OR1L8 Antikörper (AA 201-250)

Produktnummer ABIN6746645

Dieses Anti-OR1L8-Antikörper ist ein Kaninchen Polyklonal-Antikörper zur Detektion von OR1L8 in WB. Geeignet für Human und Affe.

Kurzübersicht für OR1L8 Antikörper (AA 201-250) (ABIN6746645)

Target: OR1L8 (Olfactory Receptor 1L8 (OR1L8))

Reaktivität: Human, Affe

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser OR1L8 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Produktdetails anti-OR1L8 Antikörper

Bindungsspezifität: AA 201-250

Spezifität: Human OR1L8

Homologie: Percent identity by BLAST analysis: Human (100%).

Aufreinigung: Immunoaffinity purified

Immunogen: Synthetic peptide located between aa201-250 of human OR1L8 (Q8NGR8, NP_001004454). Percent identity by BLAST analysis: Human, Gibbon, Marmoset (100%), Mouse, Rat, Elephant, Bovine, Bat, Horse, Pig, Opossum, Guinea pig, Platypus (92%), Chimpanzee, Gorilla, Galago, Hamster, Panda, Dog, Rabbit (85%), Monkey (84%).

Type of Immunogen: Synthetic peptide

Anwendungsinformationen

Applikationshinweise: Approved: WB (1 μg/mL)

Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody.

Kommentare:

Target Species of Antibody: Human

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Distilled water

Konzentration: Lot specific

Buffer: Lyophilized from PBS with 2 % sucrose

Handhabung: Avoid repeat freeze-thaw cycles.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.

Details zu OR1L8

Target: OR1L8 (Olfactory Receptor 1L8 (OR1L8))

Andere Bezeichnung: OR1L8

Hintergrund: Name/Gene ID: OR1L8
Subfamily: Olfactory
Family: GPCR

Synonyms: OR1L8, OR9-24, Olfactory receptor OR9-24, Olfactory receptor 1L8

Gen-ID: 138881

NCBI Accession: NP_001004454

UniProt: Q8NGR8